---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-301997"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2026-07-13T20:01:13+00:00"
generated_at: "2026-07-13T20:02:20.388056+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Galera Therapeutics effects 1-for-200 reverse stock split; shares to trade under GRTXD on OTCQB

## Summary
- Reverse stock split of common stock at 1:200 ratio effective July 12, 2026.
- No fractional shares; stockholders receive cash value based on closing price prior to split.
- Outstanding options and warrants adjusted proportionally with exercise price increases.
- Common stock begins trading on OTCQB under ticker GRTXD on July 13, 2026.

## SEC filing metadata
- accession: 0001193125-26-301997
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2026-07-13T20:01:13+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312526301997/0001193125-26-301997-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312526301997/d155293d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-301997
- JSON: https://secwatch.observer/filing/0001193125-26-301997.json
- Plain text: https://secwatch.observer/filing/0001193125-26-301997.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.